Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics (NYSE: DGX), a leading diagnostic information services provider, has announced a quarterly cash dividend of $0.80 per share. The dividend will be paid on July 21, 2025, to shareholders who are on record as of July 7, 2025. This regular dividend declaration demonstrates Quest's commitment to providing consistent returns to its shareholders.
Quest Diagnostics (NYSE: DGX), un importante fornitore di servizi informativi diagnostici, ha annunciato un dividendo trimestrale in contanti di 0,80 $ per azione. Il dividendo sarà pagato il 21 luglio 2025 agli azionisti registrati entro il 7 luglio 2025. Questa dichiarazione di dividendo regolare dimostra l'impegno di Quest a garantire rendimenti costanti ai suoi azionisti.
Quest Diagnostics (NYSE: DGX), un proveedor líder de servicios de información diagnóstica, ha anunciado un dividendo trimestral en efectivo de 0,80 $ por acción. El dividendo se pagará el 21 de julio de 2025 a los accionistas registrados hasta el 7 de julio de 2025. Esta declaración regular de dividendos demuestra el compromiso de Quest de ofrecer rendimientos constantes a sus accionistas.
Quest Diagnostics (NYSE: DGX)는 선도적인 진단 정보 서비스 제공업체로서, 주당 0.80달러의 분기 현금 배당금을 발표했습니다. 배당금은 2025년 7월 21일에 지급되며, 2025년 7월 7일 기준 주주 명부에 등재된 주주들에게 지급됩니다. 이번 정기 배당 발표는 퀘스트가 주주들에게 꾸준한 수익을 제공하겠다는 의지를 보여줍니다.
Quest Diagnostics (NYSE : DGX), un fournisseur leader de services d'information diagnostique, a annoncé un dividende trimestriel en espèces de 0,80 $ par action. Le dividende sera versé le 21 juillet 2025 aux actionnaires inscrits au registre au 7 juillet 2025. Cette déclaration régulière de dividende témoigne de l'engagement de Quest à offrir des rendements constants à ses actionnaires.
Quest Diagnostics (NYSE: DGX), ein führender Anbieter von diagnostischen Informationsdiensten, hat eine vierteljährliche Bardividende von 0,80 $ pro Aktie angekündigt. Die Dividende wird am 21. Juli 2025 an die Aktionäre ausgezahlt, die am 7. Juli 2025 im Aktienregister stehen. Diese regelmäßige Dividendenerklärung unterstreicht Quests Engagement, den Aktionären beständige Renditen zu bieten.
- Regular dividend payment demonstrates financial stability and commitment to shareholder returns
- Maintains consistent dividend distribution policy
- None.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302455896.html
SOURCE Quest Diagnostics